Medical Device Tax

MDMA has been the consistent and strongest voice in Congress driving the efforts to repeal the medical device tax starting when it was first proposed in 2009. While many thought that MDMA's position against the device tax was untenable and foolhardy, we never gave up fighting against this punitive policy. As a result of the passionate advocacy, Congress passed a two-year suspension of the device tax at the end of 2015.

MDMA and our members remain vigilant to permanently repeal the device tax once and for all, but suspension of this tax highlights that when innovators share the powerful stories about the lifesaving and life changing innovations they develop, we CAN change misguided policies.



Engagement by MDMA members and industry has resulted in hearings in both the House and Senate with witnesses testifying to the devastating impact of the tax, and over 1000 stakeholders signing a letter sent to Senate and House leadership calling for repeal. 

The MDMA Medical Device Tax Working Group meets on an "as needed" basis via teleconference.  Email notification will be sent to all working group participants when a call has been scheduled.  If you would like to join this working group, click here.

Latest News

MDMA Survey Highlights the Damage Device Tax Reinstatement Would Have on R&D, Jobs and Expansion Plans

MDMA's survey of 117 executives shows the danger in failing to repeal the device tax...

MDMA Statement on Tax Reform Blueprint

MDMA President and CEO Mark Leahey issued the following statement today in response to the tax reform blueprint that was issued by Republican Congressional leadership...

MDMA Survey Shows Device Tax Suspension Creating Jobs, Increasing R&D

A new survey conducted by MDMA shows that suspension of the medical device tax has led...

House Republicans Unveil Alternative Healthcare Policy Including Full Repeal of Device Tax

House Speaker Paul Ryan (WI) along with the House Chairs of healthcare committees...

MDMA Statement on First Device Tax Payment Suspension

MDMA issues the following statement today recognizing the first suspended payment...

MDMA, AdvaMed and MITA Applaud Suspension of Medical Device Tax

MDMA, AdvMed and MITA applauded Congress for passage of the two year suspension of the medical device tax...

Med Tech Coalition Applauds Historic House Vote

MDMA, AdvaMed, MITA commended the House of Representatives for passing...

MDMA Statement on House Ways & Means Committee Markup of Legislation to Repeal the Medical Device Tax

MDMA issued the following statement today in response to the House W & M Committee Markup of Legislation to Repeal the Medical Device Tax...

House Freshman Members of Congress Send Letter Urging a Vote on Device Tax Repeal

Led by Congresswoman Elise Stefanik (NY), freshman representative to the House Policy Committee, a bipartisan group of Members of the House...

MDMA Survey Shows Repealing the Medical Device Tax Would Create Jobs, Increase R&D

A new survey conducted by the Medical Device Manufactures Association (MDMA) shows that if the medical device tax was repealed, the overwhelming majority...

MDMA, AdvaMed & MITA Applaud Bipartisan Senate Effort to Repeal the Device Tax

MDMA, AdvaMed & MITA today applauded the Senate re-introduction of bipartisan legislation to repeal the increasingly damaging medical device...

MDMA, AdvaMed & MITA Support Bipartisan Efforts to Repeal the Device Tax

MDMA, AdvaMed & MITA today applauded the introduction of bipartisan legislation to repeal the 2.3 percent medical device excise...

MDMA Statement on House Jobs Package

"MDMA thanks the House of Representatives for working to strengthen medical technology innovation by removing a major roadblock..."

Treasury Inspector General Issues Report Calling IRS Collection of Medical Device Tax Problematic

A report released by the Treasury Inspector General for Tax Administration (TIGTA) showed that collecting and estimating payments from device companies for the medical device excise tax is becoming increasingly problematic….

MDMA Statement on Medical Device Tax Repeal Efforts in Senate Finance Committee

"While we are disappointed the medical device tax was not addressed as a part of the tax extenders legislation, we remain enthusiastic about the growing bipartisan agreement that Congress..."

MDMA Statement on Device Tax Repeal Inclusion in Tax Reform Plan

Mark Leahey, President & CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement regarding inclusion of medical device tax repeal in House Ways and Means Chairman Dave Camp's Tax reform plan